The historical rank and industry rank for Aurobindo Pharma's OCF Margin % or its related term are showing as below:
BOM:524804'
s OCF Margin % Range Over the Past 10 Years
Min: 8.48 Med: 13.04 Max: 22.36
Current: 16.55
During the past 13 years, the highest OCF Margin % of Aurobindo Pharma was 22.36%. The lowest was 8.48%. And the median was 13.04%.
BOM:524804's OCF Margin % is ranked better than 70.14% of 961
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs BOM:524804: 16.55
Aurobindo Pharma OCF Margin % Related Terms
Aurobindo Pharma OCF Margin % Historical Data
* Premium members only.
The historical data trend for Aurobindo Pharma's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aurobindo Pharma's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurobindo Pharma OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aurobindo Pharma's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Aurobindo Pharma's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurobindo Pharma (BOM:524804) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aurobindo Pharma and its competitors. Over the past decade, Aurobindo Pharma's OCF Margin % has ranged from 8.48 to 22.36. According to the industry distribution chart, Aurobindo Pharma ranks #287 out of 961 companies in the Drug Manufacturers industry, placing it in the top 29.9%.
Is Aurobindo Pharma's OCF Margin % too high?
Aurobindo Pharma's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 8.48 to a high of 22.36. Based on the distribution chart, Aurobindo Pharma ranks #287 out of 961 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Aurobindo Pharma has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aurobindo Pharma's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aurobindo Pharma ranks #287 out of 961 companies for OCF Margin %. This puts Aurobindo Pharma in the upper half of its industry. The industry median OCF Margin % is 9.94. Historically, Aurobindo Pharma's own OCF Margin % has ranged from 8.48 to 22.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aurobindo Pharma and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurobindo Pharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurobindo Pharma stock overvalued right now?
Based on GuruFocus' analysis, Aurobindo Pharma (BOM:524804) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,325.21, compared to a current price of ₹1,560.05 — trading 17.7% above its estimated fair value. The current OCF Margin % is 0.00%. Aurobindo Pharma's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Aurobindo Pharma (BOM:524804), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurobindo Pharma (BOM:524804) Overvalued in 2026?
Based on GuruFocus' analysis, Aurobindo Pharma stock appears to be overvalued.
The current stock price of ₹1,560.05 is trading 17.7% above its estimated GF Value™ of ₹1,325.21.
GuruFocus considers Aurobindo Pharma to be Modestly Overvalued.
Key valuation signals for BOM:524804:
OCF Margin %: 0.00%
GF Value™: ₹1,325.21 vs. price of ₹1,560.05 (17.7% above fair value)
No single metric tells the full story. See the BOM:524804 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.
85GF Score
Get the complete analysis for BOM:524804
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524804 has been successfully added to your 
